Azimuth Capital Management’s Abiomed Inc ABMD Stock Holding History

Azimuth Capital Management’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$9.2M	Buy	27,772 +1,369	+5%	+$421K	0.39%	90
2021 Q4	$9.48M	Sell	26,403 -1,085	-4%	-$367K	0.38%	98
2021 Q3	$8.95M	Sell	27,488 -238	-0.9%	-$80.6K	0.38%	100
2021 Q2	$8.65M	Buy	27,726 +802	+3%	+$246K	0.37%	99
2021 Q1	$8.58M	Buy	26,924 +1,805	+7%	+$578K	0.41%	88
2020 Q4	$8.14M	Sell	25,119 -74	-0.3%	-$20.5K	0.4%	93
2020 Q3	$6.98M	Buy	25,193 +24,338	+2,847%	+$7.01M	0.41%	86
2020 Q2	$207K	Buy	+855	New	+$172K	0.01%	266

Other funds holding ABMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Azimuth Capital Management's ABMD Position: Q1 2022 in Review

Azimuth Capital Management increased its Abiomed Inc (ABMD) stake by 5.2% in Q1 2022, buying an estimated $421K and bringing the position to 27,772 shares worth $9.2M. The position accounts for 0.39% of the portfolio, ranked #90.

Azimuth Capital Management first reported a position in ABMD in Q2 2020 and has held it in 8 quarters since. The position peaked at $9.48M in Q4 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

Azimuth Capital Management held 27,772 shares of Abiomed Inc worth $9.2M as of Q1 2022.
Azimuth Capital Management bought 1,369 Abiomed Inc shares in Q1 2022, an estimated $421K.
Abiomed Inc made up 0.39% of Azimuth Capital Management's portfolio in Q1 2022, its #90 holding.
Azimuth Capital Management first reported a position in Abiomed Inc in Q2 2020 and has held it in 8 quarters since.
Azimuth Capital Management's Abiomed Inc position peaked at $9.48M in Q4 2021.
500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Azimuth Capital Management's 13F filing for Q1 2022, filed 13 May 2022.